Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab–Naïve Relapsed Multiple Myeloma

SIMPLE SUMMARY: We have been studying different combinations of medications to treat relapsed or refractory multiple myeloma. Among these combinations, one includes daratumumab with pomalidomide and dexamethasone (DPd), and another includes daratumumab with bortezomib and dexamethasone (DVd). So far...

Descripción completa

Detalles Bibliográficos
Autores principales: Afrough, Aimaz, Atrash, Shebli, Paul, Barry, Ouchveridze, Evguenia, Ahmed, Nausheen, Mahmoudjafari, Zahra, Bashir, Anam, Alkharabsheh, Omar, Hashmi, Hamza, Abdallah, Al-Ola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571914/
https://www.ncbi.nlm.nih.gov/pubmed/37835587
http://dx.doi.org/10.3390/cancers15194894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571914/
https://www.ncbi.nlm.nih.gov/pubmed/37835587
http://dx.doi.org/10.3390/cancers15194894

Ejemplares similares